Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Surg Obes Relat Dis. 2020 Apr 19;16(8):1011–1021. doi: 10.1016/j.soard.2020.04.011

Figure 3.

Figure 3.

Modeleda percentage and 95% confidence intervals of participants categorized as intermediate/highb or high CVD risk by time since lowest weight, stratified by sex.

Abbreviations: ASCVD, Atherosclerotic cardiovascular disease; BMI, Body Mass Index (kg/m2); CVD, cardiovascular disease.

a Adjusted for factors related to missing follow-up data (i.e. site, age and current smoking status at pre-surgery). All pairwise comparison tests (for pre-surgery vs 1 year, 1 year vs 7 years and pre-surgery vs 7 years) were significant (p ≤0.01) with the exception of 1 year vs 7 years.

b Because the Framingham intermediate risk category can be used to initiate statin therapy, the Framingham intermediate and high risk groups were combined.

c A linear term for time since lowest weight recorded was significant (p ≤0.05) for all CVD scores with the exception of 10-year ASCVD in females (p=0.92) and males (p=0.06).